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Abstract
Introduction: Prostate cancer is the most common male malignancy in Togo. Most patients present with
advanced and metastatic disease. Skin metastasis from prostate cancer is very rare and it occurs late and
often with a poor prognosis. We report a case in a 52-year-old Togolese man where the skin lesions reveal
the disease and with a good prognosis three years after treatment.
Observation: In 2012, a 52-year-old man presented in dermatology with multiple painless skin nodules
on his chest. He did not have lower urinary tract symptoms The biopsy of the skin lesion (three nodules)
showed a metastasis of adenocarcinoma type tumor and tumor markers performed pointed toward prostate
as primary site. In urology a diagnostic biopsy (12 cores) of prostate revealed a high-grade (Gleason grade
4 + 4) adenocarcinoma. We performed a bilateral orchiectomy as androgen deprivation therapy and one
month after this treatment the skin lesions have disappeared.
Conclusion: Skin metastasis of prostate cancer is rare and their recognition remains poor among practition-ons. T
l Surgeons Association. Production and hosting by Elsevier B.V. This is an open
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).ers requiring biopsy of the lesi
© 2016 Pan African Urologica
access article underPlease cite this article in press as: Tengue K, et al. Prostate cancer reve
J Urol (2016), http://dx.doi.org/10.1016/j.afju.2016.10.003
Abbreviations: ADT, androgen deprivation therapy; PSA, prostate specific a
∗ Corresponding author at: Urology Department, CHU Sylvanus Olympio, P.O.
E-mail addresses: drtenguekodjo@yahoo.fr, kevin tg@yahoo.fr, tenguekodjo88@
Peer review under responsibility of Pan African Urological Surgeons’ Associatio
http://dx.doi.org/10.1016/j.afju.2016.10.003
1110-5704/© 2016 Pan African Urological Surgeons Association. Production a
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).he prognosis could be better in newly diagnosed prostate cancer.aled by skin metastasis: A case report in black African man. Afr
ntigen; DRE, digital rectal examination.
Box 14148, Lome, Togo.
yahoo.fr (K. Tengue).
n.
nd hosting by Elsevier B.V. This is an open access article under the CC
 IN PRESSA
2 K. Tengue et al.
I
P
t
[
[
d
l
i
d
s
p
W
t
a
C
I
m
s
d
a
b
s
c
p
f
p
6
F
S
s
d
c
H
b
c
t
9
gARTICLEFJU-324; No. of Pages 4
ntroduction
rostate cancer is the most common malignant neoplasm in men and
he second cause of cancer-relatedmortality inmen after lung cancer
1]. Also in Togo (West Africa) it is the most common cancer in men
2]. In Africa most patients present with advanced and metastatic
isease. The common sites of this metastasis are bones and pelvic
ymph nodes. Metastasis to skin is rarely reported with a published
ncidence of 0.36% [3]. Cases in nativeAfricans are very uncommon
espite the high incidence of the disease in this population. This
kin metastasis usually occurs late in patients who then have a poor
rognosis [4].
e hereby report a case where the skin nodules are the first symp-
oms of the disease andwith a clinically durable response three years
fter treatment by a bilateral orchiectomy.
ase report
n October 2012, a 52 year-old African man presented in der-
atology with nodular lesions. On examination, he had multiple
ubcutaneous nodules on his trunk. He reported that these lesions
eveloped abruptly over a three-weeks period. The nodules were
symptomatic, painless and had not been previously treated. The
iopsy of these skin lesions (three nodules) revealed gland-like
tructures (Fig. 1)which showed that it was ametastasis of an adeno-
arcinoma type tumor. Tumor markers performed on serum samplesPlease cite this article in press as: Tengue K, et al. Prostate cancer reve
J Urol (2016), http://dx.doi.org/10.1016/j.afju.2016.10.003
ointed toward prostate as primary site [Carcinoembryonic Antigen
or colon: 3.6 ng/mL (<10 ng/mL), Carbohydrate Antigen 19–9 for
ancreatic tumor: 4, 56 U/mL (<35 U/mL), PSA for prostate cancer:
5 ng/mL (0–4 ng/mL)].
e
n
t
a
Figure 2 Skin metastatic nodules (A) which disappearedigure 1 Tumor glands fused giving polyadenoides aspects.
o the patient has been referred to urology for management. He pre-
ented to our clinic in urology four month after he had been seen in
ermatology. On examination the nodules had spread on the entire
hest and the abdomen. He lost weight and was unable to go to work.
e did not have lower urinary tract symptoms neither hematuria, nor
ack pain. There was no illness in the patient history and no prostate
ancer disease in the family. On digital rectal examination (DRE),
he prostatewas enlarged, hard and nodular. His new serumPSAwas
6 ng/mL. A diagnostic prostate biopsy (12 cores) revealed a high-
rade (Gleason grade 4 + 4) adenocarcinoma on hematoxylin andaled by skin metastasis: A case report in black African man. Afr
osin section. A CT scan of the chest, abdomen and pelvis revealed
o widespread visceral lesions but pelvic lymph nodes dissemina-
ion. The bones scintigraphy was not performed because it was not
vailable in the country. So the prostate adenocarcinoma with skin
one month after the androgen deprivation therapy (B).
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Prostate cancer with skin metastasis
metastasis was confirmed and treatment alternatives were explained
and discussed with him.
Then we performed a bilateral orchiectomy as androgen depriva-
tion therapy two weeks after he has been seen in urology. One
month after this treatment the skin lesions had disappeared (Fig. 2).
Two months later he returned to work. From 96 ng/mL before the
treatment, the serum PSA level came down to 12,3 ng/mL after 1
month, to 3,5 ng/mL after 3 months, to 1,4 ng/mL after one year and
0,17 ng/mL after three years.
Discussion
The incidence of prostatic cancer has increased all over the world
since the use of prostate specific antigen (PSA) has been adopted as
a screening tool. So prostate cancer can now be diagnosed earlier,
when the disease is confined to the gland, a condition for which
treatments may cure the disease, thereby conferring a good progno-
sis [5]. However in most African countries, prostate carcinomas are
diagnosed late, at the metastatic stage [6] because of the cost of the
screening test PSA and the lack of awareness about prostate cancer.
Pelvic lymph nodes and bone are the most common sites of metas-
tasis. Nevertheless many other locations have also been identified
such as liver, lung, brain. The skin is an uncommon site of metastasis
for all cancers and constitutes 5.3% of metastatic sites [3].
Among urologic malignancies, prostate cancer ranks 3rd for metas-
tasis to the skin, after the kidney and the bladder [3]. Skin metastasis
from prostate cancer most commonly involve genitalia and supra-
pubic region [4]. Nowadays, different locations have been described
including skin metastasis on head, chest and neck [7,8]. The mech-
anism of spread of the metastasis is not entirely understood; direct
extension, lymphatic and haematogenous spread or combination of
these, have all been proposed [3]. Clinically, it has been reported
to mimic many other conditions, such as cellulitis, sebaceous cysts,
zosteriform lesions, telangiectasias, mammary Paget’s disease, Sis-
ter Joseph’s nodule, basal cell carcinoma, pyoderma, morphea, and
more, resulting in poor recognition [9]. The diagnosis is easier if
there is a history of prostatic cancer with known disseminated dis-
ease. Our patient had no complaints of urinary symptoms and the
diagnosis was determined by prostate biopsy analysis on hema-
toxylin and eosin section after pathologic evaluation of the skin
lesion and tumor marker analysis in serum. For our patient the
prostate biopsy revealed adenocarcinoma of the prostate.
Therapeutic options for cutaneous metastasis are palliative and
include excision, radiation therapy, and intralesional chemotherapy
[10]. Such therapies must be carefully selected and used on case
by case basis. But it is important to know that the treatment of the
primary malignancy may result in regression of those cutaneous
metastases. Such as the androgen deprivation therapy performed in
our case and other cases. ADT treatments is used for non-organ
confined prostate cancer with a drastic decline of circulating PSA
together with regression of skin lesions [11].
According to Wang et al. [10] and many other authors [3], the
appearance of skin metastases from genitourinary malignancies isPlease cite this article in press as: Tengue K, et al. Prostate cancer reve
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associated with a poor prognosis. The average survival is approxi-
mately seven months from the presentation of cutaneous metastasis.
But this prognosis could be better in a metastasis with a newly
diagnosed prostate cancer as in our case and others [12]. PRESS
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onclusion
utaneous metastases from prostate cancer are rare in native
fricans. Their clinical appearance may mimic other common der-
atologic disorders and definitive diagnosis requires a high index
f suspicion and analysis of skin biopsy, tumor marker in serum and
n prostate biopsy, especially if there is no history of prostate cancer
or the patient and in the family.
onsent
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ation of this case report and any accompanying images. A copy of
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his journal.
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